STOCK TITAN

Viemed Healthcare Inc - VMD STOCK NEWS

Welcome to our dedicated news page for Viemed Healthcare (Ticker: VMD), a resource for investors and traders seeking the latest updates and insights on Viemed Healthcare.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Viemed Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Viemed Healthcare's position in the market.

Rhea-AI Summary
Viemed Healthcare, Inc. announces a Quarterly Conference Call scheduled for May 7, 2024, at 11:00 a.m. ET, inviting interested parties to participate and ask questions. Financial professionals can pre-register to ask questions in advance. The call details and registration information are provided in the press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Viemed Healthcare, Inc. (NASDAQ:VMD) finalizes a strategic partnership with East Alabama Health, acquiring controlling interest in HomeMed. The collaboration aims to enhance home medical equipment services in Eastern Alabama, marking a significant milestone in Viemed's growth strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.76%
Tags
partnership acquisition
-
Rhea-AI Summary
Viemed Healthcare, Inc. reports record-breaking financial results for Q4 and full year 2023, showing significant revenue and income growth. The Company achieves a 35% increase in net revenues for Q4 2023 compared to Q4 2022, with total net revenues for the year up by 32%. Net income also sees a substantial rise, with a 43% increase for Q4 2023 and a 65% increase for the full year 2023. Adjusted EBITDA reaches $43.1 million for the year, reflecting strong financial performance. Viemed maintains a healthy cash balance and working capital, with no net debt after a successful acquisition in 2023. The Company projects continued revenue growth for Q1 2024, anticipating revenues of $49.7 million to $51.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.5%
Tags
Rhea-AI Summary
Viemed Healthcare, Inc. (NASDAQ:VMD) will host its Year End Conference Call on March 7, 2024, to discuss respiratory care and home medical equipment services. Financial professionals can pre-register to ask questions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary
Viemed Healthcare, Inc. (VMD) has received approval for the voluntary delisting of its common shares from the Toronto Stock Exchange (TSX) while maintaining its listing on the NASDAQ Capital Market. The company aims to enhance market efficiency and consolidate trading volumes on NASDAQ, creating a singular focal point and central marketplace for its common shares. The delisting is expected to contribute to increased long-term liquidity on NASDAQ and increased shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
none
-
Rhea-AI Summary
Viemed Healthcare, Inc. will participate in the Stifel 2023 Healthcare Conference on November 15, 2023, in New York, New York. Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct a presentation covering key areas of Viemed’s business at 1:15pm EST. Investors can request one-on-one meetings with management, and the presentation webcast and slides will be available live and for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
Rhea-AI Summary
Viemed Healthcare, Inc. reported its financial results for Q3 2023. Net revenues reached a record $49.4 million, a 38% increase compared to Q3 2022. Net income totaled $2.9 million, a 177% increase. Adjusted EBITDA was $12.1 million, a 73% increase. Ventilator patient count grew by 12%. The company has a cash balance of $10.1 million and $51 million available credit. Q4 2023 net revenues are expected to be $49.8 million to $51.0 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.03%
Tags
-
Rhea-AI Summary
Viemed Healthcare, Inc. will host its Quarterly Conference Call on November 2, 2023 at 11:00 a.m. ET. Interested parties may participate in the call by dialing the provided numbers. Financial professionals can pre-register to ask questions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
none
-
Rhea-AI Summary
Viemed Healthcare, Inc. to participate in investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
conferences
Rhea-AI Summary
Viemed Healthcare, Inc. reported its financial results for the three and six months ended June 30, 2023. Net revenues reached a new record of $43.3 million, a 31% increase compared to the same quarter last year. Net income for the quarter was $2.3 million, and adjusted EBITDA totaled $9.8 million, a 52% increase. The company completed its acquisition of Home Medical Products, Inc. for $28 million in cash. Viemed expects to generate net revenues of approximately $49.0 million to $50.2 million in the third quarter of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.72%
Tags
Viemed Healthcare Inc

Nasdaq:VMD

VMD Rankings

VMD Stock Data

317.03M
31.27M
12.71%
62.39%
1.05%
Dental Laboratories
Manufacturing
Link
United States
Lafayette

About VMD

viemed is a respiratory disease management company. our mission is to educate, nurture, and inspire our patients to lead better lives. we accomplish this through a highly effective home treatment model that integrates easily into the processes of our referral partners to effectively transition patients from the hospital to their home or other long-term care setting. while our respiratory care practitioners, trained as copd educators, deliver therapy and counseling to patients in their home utilizing the most effective technology available, our care consultants work with hospitals, aco’s, snf’s and other referral sources to simplify the administrative process of transitioning patients from hospital to home care. we achieve industry leading outcomes in hospital readmissions and patient satisfaction which has resulted in us becoming one of the largest home non-invasive ventilation providers in the usa.